Paraoxonase 1 polymorphisms and survival

European Journal of Human Genetics

Volumn 12, Issue 10, 2004, Pages 843-847

  Christiansen, L ^a,b   Bathum, L ^a,b   Frederiksen, H ^a   Christensen, K ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Mortality; Paraoxonase; Polymorphisms

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE LOCATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LONGEVITY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; CORONARY DISEASE; DENMARK; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 6444240618     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201235     Document Type: Article

References (20)

1. Watson AD, Berliner JA, Hama SY et al: Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995; 96: 2882-2891.
2. Mackness MI, Arrol S, Durrington PN: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991; 286: 152-154.
3. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA: Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7: 69-76.
4. Heinecke JW, Lusis AJ: Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis? Am J Hum Genet 1998; 62: 20-24.
5. Adkins S, Gan KN, Mody M, La Du BN: Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 1993; 52: 598-608.
6. Leviev I, James RW: Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 2000; 20: 516-521.
7. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998; 423: 57-60.
8. Deakin S, Leviev I, Brulhart-Meynet MC, James RW: Paraoxonase1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position -107, implicating the Sp1 transcription factor. Biochem J 2003; 372 (Part 2): 643-649.
9. Wheeler JG, Keavney BD, Watkins PH, Collins PR, Danesh PJ: Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet 2004; 363: 689-695.
10. Heijmans BT, Westendorp RG, Lagaay AM et al: Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 2000; 149:91-97.
11. Bonafe M, Marchegiani F, Cardelli M et al: Genetic analysis of paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians. Eur J Hum Genet 2002; 10: 292-296.
12. Nybo H, Gaist D, Jeune B et al: The Danish 1905 cohort: a genetic-epidemiological nationwide survey. J Aging Health 2001; 13: 32-46.
13. Christensen K, Gaist D, Vaupel JW, McGue M: Genetic contribution to rate of change in functional abilities among Danish twins aged 75 years or more. Am J Epidemiol 2002; 155: 132-139.
14. Skytthe A, Kyvik K, Holm NV, Vaupel JW, Christensen K: The Danish Twin Registry: 127 birth cohorts of twins. Twin Res 2002; 5: 352-357.
15. Gaist D, Bathum L, Skytthe A et al: Strength and anthropometric measures in identical and fraternal twins: no evidence of masculinization of females with male co-twins. Epidemiology 2000; 11: 340-343.
16. Bathum L, Christiansen L, Nybo H et al: Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch Intern Med 2001; 161: 2441-2444.
17. Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Christensen K: Modest implication of interleukin 6 promoter polymorphisms in longevity. Mech Ageing Dev 2004; 125: 391-395.
18. Sham PC, Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59 (Part 1): 97-105.
19. Chakravarti A, Buetow KH, Antonarakis SE et al: Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet 1984; 36: 1239-1258.
20. Chen Q, Reis SE, Kammerer CM et al: Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am J Hum Genet 2003; 72: 13-22.